Lucy Hicks

A new diagnostic test can accurately distinguish osteoarthritis (OA) from inflammatory arthritis using two synovial fluid biomarkers, according to research published in the Journal of Orthopaedic Research on December 18, 2024.

A new diagnostic test can accurately distinguish osteoarthritis (OA) from inflammatory arthritis using two synovial fluid biomarkers, according to research published in the Journal of Orthopaedic Research on December 18, 2024.

The Food and Drug Administration (FDA) has approved ustekinumab -stba (Steqeyma) as a biosimilar to the interleukin-12 and -23 inhibitor ustekinumab (Stelara) for the treatment of adults with active Crohn’s disease or ulcerative colitis and for both children aged ≥ 6 years and adults with moderate to severe plaque psoriasis or active psoriatic arthritis.

Orthobiologics are a rapidly advancing area in orthopedics and regenerative medicine.

Baricitinib can effectively treat polymyalgia rheumatica (PMR) without the use of oral glucocorticoids, according to results from a small, randomized, double-blind, placebo-controlled study.

Earlier this month, the US Preventive Services Task Force (USPSTF) released updated screening recommendations for osteoporosis.

Despite an increased risk for complications and death in men after fractures, the US Preventive Services Task Force maintains there’s insufficient evidence to recommend osteoporosis screening for men.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.

Biosimilars are often promoted as cost-saving alternatives to their reference medications.

A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and the risk for posttraumatic osteoarthritis.